Insufficient scRNA-seq data for expression of ELL3 at single-cell level.
Insufficient scRNA-seq data for expression of ELL3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 88% | 177.33 | 317 / 359 | 15% | 0.27 | 44 / 286 |
intestine | 87% | 511.48 | 837 / 966 | 16% | 0.27 | 86 / 527 |
esophagus | 90% | 300.48 | 1295 / 1445 | 8% | 0.11 | 14 / 183 |
prostate | 91% | 181.53 | 223 / 245 | 2% | 0.02 | 10 / 502 |
ovary | 91% | 170.07 | 163 / 180 | 1% | 0.02 | 5 / 430 |
adrenal gland | 88% | 170.70 | 228 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 88% | 166.54 | 1169 / 1335 | 0% | 0 | 0 / 0 |
lung | 85% | 153.67 | 491 / 578 | 2% | 0.03 | 23 / 1155 |
bladder | 76% | 114.43 | 16 / 21 | 8% | 0.11 | 38 / 504 |
spleen | 83% | 146.80 | 200 / 241 | 0% | 0 | 0 / 0 |
skin | 77% | 975.37 | 1397 / 1809 | 0% | 0.00 | 1 / 472 |
breast | 74% | 154.62 | 341 / 459 | 2% | 0.03 | 26 / 1118 |
uterus | 75% | 139.28 | 128 / 170 | 0% | 0.01 | 2 / 459 |
thymus | 75% | 122.66 | 492 / 653 | 0% | 0.00 | 1 / 605 |
kidney | 62% | 87.94 | 55 / 89 | 0% | 0 | 0 / 901 |
lymph node | 0% | 0 | 0 / 0 | 59% | 2.09 | 17 / 29 |
pancreas | 52% | 71.85 | 172 / 328 | 1% | 0.02 | 1 / 178 |
adipose | 53% | 79.94 | 635 / 1204 | 0% | 0 | 0 / 0 |
muscle | 48% | 74.71 | 389 / 803 | 0% | 0 | 0 / 0 |
brain | 27% | 82.90 | 715 / 2642 | 0% | 0.00 | 1 / 705 |
peripheral blood | 22% | 128.32 | 203 / 929 | 0% | 0 | 0 / 0 |
heart | 12% | 13.61 | 103 / 861 | 0% | 0 | 0 / 0 |
liver | 5% | 5.50 | 11 / 226 | 0% | 0 | 0 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0007283 | Biological process | spermatogenesis |
GO_0032786 | Biological process | positive regulation of DNA-templated transcription, elongation |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
GO_0050769 | Biological process | positive regulation of neurogenesis |
GO_0006354 | Biological process | DNA-templated transcription elongation |
GO_0061351 | Biological process | neural precursor cell proliferation |
GO_0042795 | Biological process | snRNA transcription by RNA polymerase II |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_0072089 | Biological process | stem cell proliferation |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_2000179 | Biological process | positive regulation of neural precursor cell proliferation |
GO_1902166 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0048863 | Biological process | stem cell differentiation |
GO_0010717 | Biological process | regulation of epithelial to mesenchymal transition |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0008023 | Cellular component | transcription elongation factor complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030054 | Cellular component | cell junction |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ELL3 |
Protein name | RNA polymerase II elongation factor ELL3 Elongation factor for RNA polymerase II 3 |
Synonyms | |
Description | FUNCTION: Enhancer-binding elongation factor that specifically binds enhancers in embryonic stem cells (ES cells), marks them, and is required for their future activation during stem cell specification. Does not only bind to enhancer regions of active genes, but also marks the enhancers that are in a poised or inactive state in ES cells and is required for establishing proper RNA polymerase II occupancy at developmentally regulated genes in a cohesin-dependent manner. Probably required for priming developmentally regulated genes for later recruitment of the super elongation complex (SEC), for transcriptional activation during differentiation. Required for recruitment of P-TEFb within SEC during differentiation. Probably preloaded on germ cell chromatin, suggesting that it may prime gene activation by marking enhancers as early as in the germ cells. Promoting epithelial-mesenchymal transition (EMT) (By similarity). Elongation factor component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III . . |
Accessions | C9JHD8 Q9HB65 ENST00000319359.8 [Q9HB65-1] ENST00000433927.1 |